Gonzalez, R., Havrilesky, L. J., Myers, E. R., Secord, A. A., Dottino, J. A., Berchuck, A., & Moss, H. A. (2020). Cost-effectiveness analysis comparing “PARP inhibitors-for-all” to the biomarker-directed use of PARP inhibitor maintenance therapy for newly diagnosed advanced stage ovarian cancer. Gynecol Oncol.

Gonzalez, Rafael, Laura J. Havrilesky, Evan R. Myers, Angeles Alvarez Secord, Joseph A. Dottino, Andrew Berchuck, and Haley A. Moss. "Cost-effectiveness Analysis Comparing “PARP Inhibitors-for-all” to the Biomarker-directed Use of PARP Inhibitor Maintenance Therapy for Newly Diagnosed Advanced Stage Ovarian Cancer." Gynecol Oncol 2020.

Gonzalez, Rafael, et al. "Cost-effectiveness Analysis Comparing “PARP Inhibitors-for-all” to the Biomarker-directed Use of PARP Inhibitor Maintenance Therapy for Newly Diagnosed Advanced Stage Ovarian Cancer." Gynecol Oncol 2020.